Add
ACOR to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| ACOR > SEC Filings for ACOR > Form 8-K on 7-Aug-2008 | All Recent SEC Filings |
7-Aug-2008
Entry into a Material Definitive Agreement, Other Events, Financial State
On August 6, 2008, Acorda Therapeutics, Inc. (the "Registrant") entered into an underwriting agreement (the "Underwriting Agreement") with Deutsche Bank Securities Inc. ( the "Underwriter"), relating to the issuance and sale by the Registrant of 4,000,000 shares of its common stock. The Registrant also has granted the Underwriter a 30-day option to purchase up to an additional 600,000 shares of common stock.
The offering is being made pursuant to the Registrant's shelf registration statement on Form S-3 (Registration No. 333-152826) (the "Registration Statement") filed with the Securities and Exchange Commission (the "Commission") on August 6, 2008, including a related prospectus, dated August 6, 2008, and prospectus supplement, dated August 6, 2008.
A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Form 8-K, and incorporated by reference into the Registration Statement. A copy of the opinion of Covington & Burling LLP relating to the validity of the issuance and sale of the shares in the offering is attached as Exhibit 5.2 to this Form 8-K, and incorporated by reference into the Registration Statement.
The Registrant's press release announcing the pricing of the offering pursuant to the Underwriting Agreement is attached as Exhibit 99.1 to this Current Report on Form 8-K, and incorporated herein by reference.
1.1 Underwriting Agreement, dated August 6, 2008, among Acorda
Therapeutics, Inc., and Deutsche Bank Securities Inc.
5.2 Opinion of Covington & Burling LLP
23.2 Consent of Covington & Burling LLP (included in Exhibit 5.2)
99.1 Press Release dated August 7, 2008
|
|
|